| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Maia Biotechnology, Inc. (MAIA) has 9 insiders with recent SEC Form 4 filings, including 16 buys and 0 sells. MAIA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 800.0K | $1.03M | - | |
| Other | 400.0K | $516.0K | - | |
| Other | 30.0K | $38.7K | - | |
| Dir | 29.8K | $38.4K | - | |
| Dir | 29.2K | $37.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 18, 2023 | Guerrero Ramiro | Director | Buy | 1,263 | $4.17 | $5,266.71 | +0.4% | -40.7% | -47.3% | |
| Apr 17, 2023 | Luput Cristian | Director | Buy | 1,576 | $3.69 | $5,815.44 | +0.5% | -41.6% | -46.1% | |
| Apr 14, 2023 | Luput Cristian | Director | Buy | 1,424 | $3.60 | $5,122.80 | +0.2% | -39.4% | -38.8% | |
| Apr 4, 2023 | Vitoc Vlad | Chief Executive Officer | Buy | 2,300 | $3.52 | $8,105.50 | +0.1% | -38.2% | -33.9% | |
| Mar 31, 2023 | Vitoc Vlad | Chief Executive Officer | Buy | 1,700 | $3.46 | $5,875.85 | +0.1% | -37.9% | -28.3% | |
| Mar 24, 2023 | Smith Stan | Director | Buy | 938 | $3.49 | $3,273.62 | +0.2% | -38.1% | -40.4% | |
| Mar 23, 2023 | Smith Stan | Director | Buy | 3,320 | $3.32 | $11,023.10 | +0.3% | -29.3% | -31.3% | |
| Mar 21, 2023 | Smith Stan | Director | Buy | 5,742 | $3.23 | $18,532.80 | +0.5% | -31.0% | -46.1% | |
| Mar 16, 2023 | Guerrero Ramiro | Director | Buy | 1,333 | $3.64 | $4,852.12 | +0.4% | -34.4% | -60.5% | |
| Mar 13, 2023 | Luput Cristian | Director | Buy | 8,382 | $4.02 | $33,684.18 | +1.5% | -34.8% | -65.4% |